GWPCARE
DEAD

Serial Number

86367003

Owner

GW Pharma Limited

Attorney

Michelle L. Visser

Filing Date

Aug 14, 2014

Add to watchlist:

No watchlists yet
View on USPTO

GWPCARE Trademark

Serial Number: 86367003

GWPCARE is a trademark filed by GW Pharma Limited on August 14, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 31 (Natural Agricultural Products). The application is currently no longer active.

Owner Contact Info

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Trademark Details

Filing Date

August 14, 2014

Registration Date

Not Registered

Published for Opposition

August 25, 2015

Goods & Services

Educational services, namely, classes, seminars and workshops in the fields of clinical trials, educational matters and pharmaceutical preparations and substances; tuition training services in the field of clinical trials; provision of training and instruction services in the field of clinical trials, educational and pharmaceutical preparations and substances; publication of books and texts; publishing of electronic publications provision of online electronic publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational matter and pharmaceutical preparations and substances; arranging and conducting symposiums, conferences, congresses and exhibitions for educational purposes in the field of clinical trials, educational matter and pharmaceutical preparations and substances; advisory, information and consultancy services relating to all of the aforesaid

Computer programmes for collection, editing, organizing, modifying, managing, transmission, storage and sharing of data and information for use in relation to clinical trials, educational matters and pharmaceutical preparations and substances; computer software for collection, editing, organizing, modifying, managing, transmission, storage and sharing of data and information for use in relation to clinical trials, educational matters and pharmaceutical preparations and substances; data processing apparatus; pre-recorded optical discs featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; information stored on electronic, magnetic and/or by optical means, namely, audio and video recordings featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; downloadable electronic publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; electronic teaching publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; sanitary preparations for medical purposes; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes

Paper; printed matter, namely, books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational matter and pharmaceutical preparations and substances; packing materials of paper or cardboard; wrapping paper; packaging boxes of paper, paperboard or cardboard; stationery; photographs; printed instructional and teaching material in the field of clinical trials, educational and pharmaceutical preparations and substances; printed teaching and instructional material for research on health, drugs, pharmaceuticals, medical and technical laboratory matters

Medical services; healthcare services; veterinary services; medical analysis services, namely, medical consultations; horticultural services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via the internet; providing medical information on the internet; advisory, information and consultancy services relating to all of the aforesaid

Surgical, medical, dental and veterinary apparatus, instruments and implements, namely, drug delivery systems; applicators for pharmaceutical preparations, namely, drug delivery systems; drug inhalation devices, namely, inhalers and nebulizers for medical purposes; apparatus for drug administration, namely, drug delivery systems; drug delivery devices, namely, medical syringes, and transdermal patches sold without medication; structural parts and fittings for all of the aforesaid goods

Agricultural seeds; flowers; live plants

Scientific and technological services, namely, scientific and technological research services relating to clinical trials and pharmaceutical preparations and substances; scientific research services; design services in the field of clinical trials and pharmaceutical preparations and substances; industrial design services; computer programming services; technical and scientific consultancy and research services in the field of clinical trials and pharmaceutical preparations and substances; testing and analysis of pharmaceutical preparations and substances; computerised analysis of scientific data; scientific laboratory services in the field of clinical trials and pharmaceutical preparations and substances; industrial analysis and research services in the field of clinical trials and pharmaceutical preparations and substances; medical research relating to epilepsy; analysis of medical research relating to epilepsy; chemical analysis services; chemical, biological, biotechnology and biomedical research services; research and development services in the field of clinical trials and pharmaceutical preparations and substances; conducting clinical trials for others; clinical research, namely, scientific research; providing medical research clinical trial information via a website; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory, information and consultancy services relating to all of the aforesaid

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 23, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 23, 2016 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 20, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 25, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 25, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 5, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 17, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 13, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 13, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 13, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 13, 2015 CNEA
EXAMINER'S AMENDMENT ENTERED
Jun 22, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2015 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 20, 2015 GNFN
FINAL REFUSAL E-MAILED
Apr 20, 2015 GNFR
FINAL REFUSAL WRITTEN
Apr 20, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2015 CRFA
ASSIGNED TO LIE
Mar 19, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 11, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2014 NWOS
NEW APPLICATION ENTERED
Aug 18, 2014 NWAP